|
시장보고서
상품코드
2008132
항체 칵테일 시장 : 유형별, 적응증별, 유통 채널별, 지역별Antibody Cocktails Market, By Type, By Indication, By Distribution Channel, By Geography |
||||||
항체 칵테일 시장은 2026년에 22억 달러로 추정되고 있으며, 2033년까지 73억 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 17.7%로 성장할 것으로 전망되고 있습니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준연도 | 2025년 | 시장 규모(2026년) | 22억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간의 CAGR(2026-2033년) | 17.70% | 예측 금액(2033년) | 73억 달러 |
항체(면역글로불린이라고도 함)는 항원이라는 이물질의 존재에 대해 인체의 면역체계가 생성하는 방어 단백질입니다. 항원에는 병원체, 곤충의 독, 박테리아, 바이러스 등의 독성 물질 등 다양한 물질이 포함됩니다. 항체 칵테일은 기본적으로 두 가지의 서로 다른 항체를 조합한 것입니다. 칵테일 접근법에서 두 개의 항체를 결합하는 이유는 바이러스의 변이에 의한 면역회피를 최소화하기 위함입니다.
시장 역학
시장내 주요 기업의 제휴 및 계약과 같은 비유기적 전략의 채택이 증가하면서 예측 기간 중 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어 2021년 5월 다국적 헬스케어 기업 F. 호프만 라 로슈와 다국적 제약사 시플라는 전략적 제휴를 체결했습니다. 이로써 F. 호프만 라 로슈는 자사의 항체 칵테일(카시리비맙 및 임데비맙) 제제를 인도에 수입하고, 시플라의 유통망을 통해 인도에서 판매 및 유통을 담당하게 됩니다.
또한 2020년 8월 다국적 헬스케어 기업 F. 호프만 라 로슈와 바이오테크 기업 레제네론 파마슈티컬스(Regeneron Pharmaceuticals)는 레제네론의 임상시험 중인 항바이러스 항체 칵테일 'REGN-COV2'를 개발, 제조, 전 세계 사람들에게 공급하기로 합의했다고 발표했습니다. 공급하기로 합의했다고 발표했습니다. 이번 제휴로 REGN-COV2의 공급량은 현재 생산능력의 최소 3.5배 이상 증가할 것으로 예상되며, 더 확대될 가능성도 있습니다. 이번 계약의 일환으로 레제네론은 미국내 REGN-COV2의 유통을 담당하고, 로슈는 미국 외 지역에서의 유통을 담당하게 됩니다.
이 보고서의 주요 특징
- 세계의 항체 칵테일 시장에 대해 조사 분석했으며, 2020년을 기준연도로 하여 예측 기간(2021-2028년) 시장 규모와 CAGR을 조사하여 전해드립니다.
- 또한 각 부문의 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요 인사이트를 제공합니다.
- 세계의 항체 칵테일 시장의 주요 기업 개요을 회사 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 매개 변수를 기반으로 정리하여 수록하고 있습니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- '세계의 항체 칵테일 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 항체 칵테일 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 항체 칵테일 시장 : 유형별(2026-2033년)
제5장 세계의 항체 칵테일 시장 : 적응증별(2026-2033년)
제6장 세계의 항체 칵테일 시장 : 유통 채널별(2026-2033년)
제7장 세계의 항체 칵테일 시장 : 지역별(2026-2033년)
제8장 경쟁 구도
제9장 섹션
KSAAntibody Cocktails Market is estimated to be valued at USD 2.2 Bn in 2026 and is expected to reach USD 7.3 Bn by 2033, growing at a compound annual growth rate (CAGR) of 17.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.2 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 17.70% | 2033 Value Projection: | USD 7.3 Bn |
An antibody, also called immunoglobulin, is a protective protein produced by the immune system of the body in response to the presence of a foreign substance, called an antigen. Antigens are a wide range of substances that include disease-causing organisms and toxic materials such as insect venom, bacteria, or viruses. An antibody cocktail is basically a combination or cocktail of two different antibodies. The rationale behind combining two antibodies in a cocktail approach is to minimize mutational viral escape.
Market Dynamics
The increasing adoption of inorganic strategies such as partnerships and agreements by key players in the market is expected to drive the market growth during the forecast period. For instance, in May 2021, F. Hoffmann-La Roche Ltd., a multinational healthcare company, and Cipla Inc., a multinational pharmaceutical company, entered into a strategic partnership by which F. Hoffmann-La Roche Ltd., will import its antibody cocktail (Casirivimab and Imdevimab) medication into India, where it will then be marketed and distributed by the Cipla's distribution network.
Moreover, in August 2020, F. Hoffmann-La Roche Ltd., a multinational healthcare company, and Regeneron Pharmaceuticals Inc., a biotechnology company, announced that they had agreed to develop, manufacture, and distribute REGN-COV2, Regeneron's investigational antiviral antibody cocktail, to people around the globe. This collaboration is expected to increase the supply of REGN-COV2 by at least three and a half times the current capacity, with the potential for even further expansion. As a part of this agreement, Regeneron will be responsible for distributing REGN-COV2 in the U.S. and Roche will distribute it outside the U.S., as a part of this agreement.
Key features of the study
- This report provides an in-depth analysis of the global antibody cocktails market, and provides market size (US$ million) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global antibody cocktails market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Cipla Inc., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc., Zydus Cadila, AstraZeneca, Aridis Pharmaceuticals Inc., Immunome Inc., Celltrion Healthcare Co., Ltd., and Eli Lilly and Company
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global antibody cocktails market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibody cocktails market
Market Segmentation
- By Type
- Monovalent Antibody
- Polyvalent Antibody
- By Indication
- COVID-19
- Cancer
- HIV
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Cipla Inc.
- Hoffmann-La Roche Ltd
- Regeneron Pharmaceuticals Inc.
- Zydus Cadila
- AstraZeneca
- Aridis Pharmaceuticals Inc.
- Immunome Inc.
- Celltrion Healthcare Co.,Ltd.
- Eli Lilly and Company.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Pipeline Analysis
- Regulatory Scenario
- Reimbursement Scenario
- Product Launches
- PEST Analysis
4. Global Antibody Cocktails Market, By Type, 2026 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- Monovalent antibody
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Polyvalent antibody
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Antibody Cocktails Market, By Indication, 2026 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- COVID-19
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- HIV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Antibody Cocktails Market, By Distribution Channel, 2026 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Antibody Cocktails Market, By Region, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021-2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Cipla Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Regeneron Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zydus Cadila
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aridis Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZene Immunome Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Celltrion Healthcare Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
